MedPath

BioGene Pharmaceutical Ltd.

Ownership
Private
Employees
-
Market Cap
-
Website

Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis

Phase 1
Withdrawn
Conditions
Endometriosis Ovary
Endometriosis
Endometriosis Externa
Endometriosis, Rectum
Interventions
Biological: Linifanib
Drug: BIBW2992
Drug: Axitinib
First Posted Date
2018-03-29
Last Posted Date
2021-10-29
Lead Sponsor
BioGene Pharmaceutical Ltd.
Registration Number
NCT03481842
Locations
🇨🇭

BioGene Pharmaceutical Ltd., Basel, Вâlе, Switzerland

© Copyright 2025. All Rights Reserved by MedPath